Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing ...

HHS’s Health Resources and Services Administration released updated guidance for cervical cancer screening, which includes a ...

Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indications ...

Enforcement alone is failing. A new governance model—integrating forensic science, community care, and real-time intelligence ...

Recent advances in cancer biology have revealed that refractory malignancies, such as castration-resistant prostate cancer, pancreatic ductal ...

Autolus Therapeutics plc , a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first Integrated ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

The topic of AI and its implications for orthopedic surgeons became of high personal importance when Bill Gates predicted that AI would replace physicians and others within the next decade. As an ...

Here are the top 25 stories of 2025 from Airways, ranked by readership numbers and updated for our year-end wrap-up.